These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 15207541)

  • 61. Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drug.
    Zhang WL; Gu X; Bai H; Yang RH; Dong CD; Liu JP
    Int J Pharm; 2010 May; 391(1-2):313-21. PubMed ID: 20214958
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex.
    Kasongo KW; Shegokar R; Müller RH; Walker RB
    Drug Dev Ind Pharm; 2011 Apr; 37(4):396-407. PubMed ID: 20923388
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Physical and chemical stability of nanostructured lipid drug carriers (NLC) based on natural lipids from Baikal region (Siberia, Russia).
    Averina ES; Müller RH; Popov DV; Radnaeva LD
    Pharmazie; 2011 May; 66(5):348-56. PubMed ID: 21699068
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chemical stability of lipid excipients in SLN-production of test formulations, characterisation and short-term stability.
    Radomska-Soukharev A; Müller RH
    Pharmazie; 2006 May; 61(5):425-30. PubMed ID: 16724540
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 5-Fluorouracil in topical liposome gels for anticancer treatment--formulation and evaluation.
    Glavas-Dodov M; Fredro-Kumbaradzi E; Goracinova K; Calis S; Simonoska M; Hincal AA
    Acta Pharm; 2003 Dec; 53(4):241-50. PubMed ID: 14769231
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam.
    Khalil RM; Abd-Elbary A; Kassem MA; Ghorab MM; Basha M
    Pharm Dev Technol; 2014 May; 19(3):304-14. PubMed ID: 23528038
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems.
    Uner M
    Pharmazie; 2006 May; 61(5):375-86. PubMed ID: 16724531
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy.
    Jores K; Haberland A; Wartewig S; Mäder K; Mehnert W
    Pharm Res; 2005 Nov; 22(11):1887-97. PubMed ID: 16132349
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Preparation of solid lipid nanoparticles loaded with all-trans retinoic acid and their evaluation in vitro and in vivo].
    Hu LD; Tang X; Cui FD
    Yao Xue Xue Bao; 2005 Jan; 40(1):71-5. PubMed ID: 15881775
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Preparation of tetrandrine solid lipid nanoparticles].
    Li YC; Dong L; Jia A; Chang XM; Xue H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):686-9. PubMed ID: 17121232
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Semisolid SLN dispersions for topical application: influence of formulation and production parameters on viscoelastic properties.
    Lippacher A; Müller RH; Mäder K
    Eur J Pharm Biopharm; 2002 Mar; 53(2):155-60. PubMed ID: 11879997
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin.
    Ridolfi DM; Marcato PD; Justo GZ; Cordi L; Machado D; Durán N
    Colloids Surf B Biointerfaces; 2012 May; 93():36-40. PubMed ID: 22244299
    [TBL] [Abstract][Full Text] [Related]  

  • 73. QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment.
    Amasya G; Aksu B; Badilli U; Onay-Besikci A; Tarimci N
    Int J Pharm; 2019 May; 563():110-121. PubMed ID: 30935913
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nanostructured lipid carrier-based hydrogel formulations for drug delivery: a comprehensive review.
    Doktorovova S; Souto EB
    Expert Opin Drug Deliv; 2009 Feb; 6(2):165-76. PubMed ID: 19239388
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lipid nanoparticles for improved topical application of drugs for skin diseases.
    Schäfer-Korting M; Mehnert W; Korting HC
    Adv Drug Deliv Rev; 2007 Jul; 59(6):427-43. PubMed ID: 17544165
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Investigation of a new injectable thermosensitive hydrogel loading solid lipid nanoparticles.
    Guo X; Cui F; Xing Y; Mei Q; Zhang Z
    Pharmazie; 2011 Dec; 66(12):948-52. PubMed ID: 22312700
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Structural investigations on lipid nanoparticles containing high amounts of lecithin.
    Schubert MA; Harms M; Müller-Goymann CC
    Eur J Pharm Sci; 2006 Feb; 27(2-3):226-36. PubMed ID: 16298113
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nanostructured lipid carriers system: recent advances in drug delivery.
    Iqbal MA; Md S; Sahni JK; Baboota S; Dang S; Ali J
    J Drug Target; 2012 Dec; 20(10):813-30. PubMed ID: 22931500
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy.
    Jores K; Mehnert W; Drechsler M; Bunjes H; Johann C; Mäder K
    J Control Release; 2004 Mar; 95(2):217-27. PubMed ID: 14980770
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development and in vitro evaluation of lipid nanoparticle-based dressings for topical treatment of chronic wounds.
    Gainza G; Chu WS; Guy RH; Pedraz JL; Hernandez RM; Delgado-Charro B; Igartua M
    Int J Pharm; 2015 Jul; 490(1-2):404-11. PubMed ID: 26043822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.